Besides, targeting protein degradation has emerged as a strategy in cancer therapy via PROTAC or deubiquitylase enzyme inhibitors,59, 60 which may also be a potential strategy of targeting GPX8 for LUAD metastasis with the further study of GPX8 degradation in the future. This evidence concerns the gene GPX8 and cancer.